Comparative genomic hybridization analysis of human neuroblastomas: Detection of distal 1p deletions and further molecular genetic characterization of neuroblastoma cell lines

Cancer Genetics and Cytogenetics

Volumn 97, Issue 2, 1997, Pages 135-142

  Van Roy, Nadine ^a   Jauch, Anna ^c   Van Gele, Mireille ^a   Laureys, Geneviève ^a   Versteeg, Rogier ^b   De Paepe, Anne ^a   Cremer, Thomas ^c   Speleman, Frank ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 1P; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE ACTIVATION; GENE AMPLIFICATION; GENE DELETION; GENE LOCATION; HUMAN; HUMAN CELL; KARYOTYPE; MOLECULAR GENETICS; NEUROBLASTOMA; PRIORITY JOURNAL; RELIABILITY; TUMOR SUPPRESSOR GENE;

CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOME BANDING; CHROMOSOME DELETION; CHROMOSOME DISORDERS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 17; GENE AMPLIFICATION; GENES, MYC; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; NEUROBLASTOMA; NUCLEIC ACID HYBRIDIZATION; SEQUENCE DELETION;

EID: 0030789270     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(96)00362-7     Document Type: Article

References (31)

1. Brodeur GM, Fong CT (1989): Molecular biology and genetics of human neuroblastoma. Cancer Genet Cytogenet 41:153-174.
2. Fong C, White PS, Peterson K, Sapienza C, Cavenee WK, Kern SE, Vogelstein B, Cantor AB, Look AT, Brodeur GM (1993): Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas. Cancer Res 52:1780-1785.
3. Srivatsan ES, Ying KL, Seeger RC (1993): Deletion of chromosome 11 and of 14q sequences in neuroblastoma. Genes Chromosom Cancer 7:32-37.
4. Savelyeva L, Corvi R, Schwab M (1994): Translocation involving 1p and 17q is a recurrent genetic alteration of human neuroblastoma cells. Am J Hum Genet 55:334-340.
5. Van Roy N, Laureys G, Ching Cheng N, Willem P, Opdenakker G, Versteeg R, Speleman F (1994): 1;17 translocations and other chromosome 17 rearrangements in human primary neuroblastoma tumor and cell lines. Genes Chromosom Cancer 10:103-114.
6. Van Roy N, Cheng NC, Laureys G, Opdenakker G, Versteeg R, Speleman F (1995): Molecular cytogenetic analysis of 1;17 translocations in neuroblastoma. Eur J Cancer 4:530-535.
7. Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY, Hammond D (1985): Association of multiple copies of the MYCN oncogene with rapid progression of neuroblastomas. N Engl J Med 313:1111-1116.
8. Tsuda T, Obara M, Hirano H, Gotoh S, Kubomura S, Higashi K, Kuroiwa A, Nakagawara A, Nagahara N, Shimuzu K (1987): Analysis of MYCN amplification in relation to disease stage and histologic types in human neuroblastomas. Cancer 60:820-826.
9. Corvi R, Savelyeva L, Breit S, Wenzel A, Handgretinger R, Barak J, Oren M, Amler L, Schwab M (1995): Non-syntenic amplification of MDM2 and MYCN in human neuroblastomas. Oncogene 10:1081-1086.
10. Van Roy N, Forus A, Myklebost O, Cheng N, Versteeg R, Speleman F (1995): Identification of two distinct chromosome 12-derived amplification units in neuroblastoma cell line NGP. Cancer Genet Cytogenet 82:151-154.
11. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray J, Waldman F, Pinkel D (1992): Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818-821.
12. du Manoir S, Speicher MR, Joos S, Schröck E, Popp S, Donner H, Kovacs G, Robert-Nicoud M, Lichter P, Cremer T (1993): Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization. Hum Genet 90:590-610.
13. Speicher MR, du Manoir S, Schröck E, Holtgreve-Grez H, Schoell B, Lengauer C, Cremer T, Ried T (1993): Molecular cytogenetic analysis of formalin-fixed, paraffin-embedded solid tumors by comparative genomic hybridization after universal DNA-amplification. Hum Mol Genet 11:1907-1914.
14. Kallioniemi OP, Kallioniemi A, Kurisu W (1992): ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization. Proc Natl Acad Sci USA 89:5321.
15. Cheng NC, Van Roy N, Chan A, Beitsma M, Westerveld A, Speleman F, Versteeg R (1995): Analysis of chromosome 1p deletions and MYCN activation in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35-36 region. Oncogene 10:291-297.
16. Tumilowicz JJ, Nichols WW, Cholon JJ, Greene AE (1970): Definition of a continuous cell line derived from neuroblastoma. Cancer Res 30:2110-2118.
17. Sugimoto T, Tatsumi E, Kemshead JT, Helson L, Green AA, Minowada J (1984): Determination of cell surface membrane antigens common to both human neuroblastoma and leukemia-lymphoma cell lines by a panel of 38 monoclonal antibodies. J Natl Cancer Inst 73:51-57.
18. Donti E, Long L, Tonini GP, Verdona G, Melodia A, Lanino E, Cornaglia-Ferraris (1988): Cytogenetic and molecular study of two human neuroblastoma cell lines. Cancer Genet Cytogenet 30:225-231.
19. Brodeur GM, Sekhon GS, Goldstein MN (1977): Chromosomal aberrations in human neuroblastomas. Cancer 40:2256-2263.
20. Cowell JK, Rupniak HT (1983): Chromosome analysis of human neuroblastoma cell line showing double minutes and an aberration involving chromosome 1. Cancer Genet Cytogenet 9:273-280.
21. Reynolds CP, Biedler JL, Spengler BA, Reynolds DA, Ross RA, Frenkel EP, Smith RG (1986): Characterization of human neuroblastoma cell lines established before and after therapy. J Natl Cancer Inst 76:375-387.
22. Speleman F, Van Roy N, Wiegant J, Dierick AM, Uyttendaele D, Leroy JG (1992): Molecular cytogenetic analysis of a complex t(10;11;22) translocation in E wing's sarcoma. Genes Chromosom Cancer 4:188-191.
23. Sambrook J, Fritsch EF, Maniatis T (1989): Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
24. du Manoir S, Schröck E, Bentz M, Speicher MR, Joos S, Ried T, Lichter P, Cremer T (1995): Quantitative analysis of comparative genomic hybridization. Cytometry 19:27-41.
25. Collins C, Kuo WL, Segraves R, Fuscoe J, Pinkel D, Gray JW (1991): Construction and characterization of plasmid libraries enriched in sequences from single human chromosomes. Genomics 11:997-1006.
26. Hoovers JMN, Mannens M, John R, Bliek J, van Heyningen V, Porteous DJ, Leschot NJ, Westerveld A (1991): High resolution localization of 69 potential human zinc finger protein genes: a number are clustered. Genomics 12:254-263.
27. Amler LC, Corvi R, Praml C, Saveyeva L, Le Paslier D, Schwab M (1995): A reciprocal translocation (1;15)(p36.2;q24) in a neuroblastoma cell line is accompanied by DNA duplication and may signal the site of a putative tumor suppressor gene. Oncogene 10:1095-1101.
28. Muresu R, Casciano I, Volpi EV, Sinsicalco M, Romani M (1995): Cytogenetic and molecular studies on the neuroblastoma cell line NGP: Identification of a reciprocal t(1;15) involving the "consensus region" 1p36.1. Genes Chromosom Cancer 13:66-71.
29. Shiloh Y, Shipley J, Brodeur GM, Bruns G, Korf B, Donlon T, Shreck RRR, Seeger R, Sakai K, Latt SA (1985): Differential amplification, assembly and relocation of multiple DNA sequences in human neuroblastomas and neuroblastoma cell lines. Proc Natl Acad Sci USA 82:3761-3765.
30. Caron H, Van Sluis P, Van Roy N, De Kraker J, Speleman F, Voute PA, Westerveld A, Slater R, Versteeg R (1994): Recurrent 1;17 translocations in human neuroblastoma reveal non-homologous recombination during the S/G2 phase as a novel mechanism for LOH. Am J Hum Genet 53:341-347.
31. Corvi R, Savelyeva L, Schwab M (1995): Duplication of N-myc at its resident site 2p24 may be a mechanism of activation alternative to amplification in human neuroblastoma cells. Cancer Res 55:3471-3474.